Scientists achieve significant stem-cell breakthrough

 

In the study, a team led by Juan Carlos Izpisúa Belmonte, of the Salk Institute in La Jolla, California, extracted cells from six patients with a rare genetic disease called Fanconi anemia. This recessive genetic disorder, which causes bone marrow failure, luekemia and other cancers, is often fatal unless the patient is able to undergo a bone marrow transplant from a perfectly matched donor.

To correct the gene that causes the disease, the researchers infected the extracted cells with a genetically modified virus, which were then reprogrammed into an embryo-like state to create induced pluripotent stem cells (IPS cells). When the IPS cells were grown in culture, they developed into the type of blood progenitor cells that are required for transplant in therapies used with Fanconi anemia patients. Because the IPS cells had been corrected, they no longer had the genetic defect that causes the disease - yet were genetically identical to the patient's own tissue and should be able to be transplanted without the risk of rejection by the body's immune system. Their work was recently published online in the journal, Nature.

"We haven't cured a human being, but we have cured a cell. In theory we could transplant it into a human and cure the disease," says Professor Belmonte, who notes that their work has taken more than two years already. "In principle, our approach could be used with any disease that could be corrected by gene therapy and where there is loss or alteration of a specific cell type," he adds.

Additional work needs to be done to improve the technology in order to produce cells that can be safely transplanted into patients. As Chris Mathew, a molecular geneticist at King's College London, writes in a statement: "The current reprogramming and gene therapy techniques - which both involve introducing foreign DNA with potentially cancer-causing viruses - are not suitable for therapeutic application, but researchers are working on developing safer reprogramming methods."

News Release: Patched-up human cells  www.the-scientist.com May 31, 2009

News Release: Stem cells without genetic defects heralded as breakthrough

www.timesonline.co.uk  June 1, 2009

 


Health Headlines

Language and memory tests can reliably predict when a healthy elderly person is likely to develop mild cognitive impairment, a precursor to dementia
Rush University Medical Center (USA) embarks on a research study to ascertain how microbial imbalances may impact diseases such as breast cancer.
Yale University researchers report improved function of the blood vessel lining and reduced cholesterol levels in diabetics who consume walnuts daily.
Routine moderate exercise can reduce the risk of premature death in people with heart problems by up to 60%.
Added as a sweetener to many processed foods and beverages, fructose (also known as high fructose corn syrup), may increase blood pressure.
Diets high in sodium and artificially sweetened soda linked to kidney function decline.
Antioxidant compounds retard the ability of influenza virus to damage a key protein in lungs
Studying an animal model of spinal cord injury, UCSD researchers report successful regeneration of nerve cells even when treatment is delayed.
Gallup Survey finds that 11.3% of American adults have diabetes, and the trend upwards is projected to continue unless aggressive interventions are implemented.
More than 11% of American adults surveyed say they failed to enjoy a day in the previous month where they got enough sleep.
Looking for an Anti-aging Doctor?

upcoming Events

U.S. Events
congresses
Las Vegas
fellowships
fellowships
symposium
workshops
  • Advanced Hormone Symposium
    Chicago, IL | Oct. 8-10, 2010

VIDEO: Bio-Identical Hormone
          Replacement

Dr. Sangeeta Pati, one of the world’s foremost educators and practicing physicians in the field of HRT shared “The Nuts and Bolts of Hormone Restoration” via webinar. View the Webinar.

International Events
See all events »